Synthesis of 1,2,5-tri-o-benzoyl-3-dibenzylamino-3-deoxyribose as intermediate for producing 3′-amino-3′-deoxyadenosine and 3′-amino-3′-deoxyguanosine and the protected derivatives thereof

US12060384B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-12060384-B2
Application numberUS-202017428548-A
CountryUS
Kind codeB2
Filing dateFeb 5, 2020
Priority dateFeb 5, 2019
Publication dateAug 13, 2024
Grant dateAug 13, 2024

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

The invention generally relates to improved processes for the preparation of intermediates of a cyclic dinucleotide which is useful as a STING agonist.

First claim

Opening claim text (preview).

We claim: 1. A process for preparing Compound 8 of the formula: comprising the steps of a) reacting Compound 1 in a benzoyl protection reaction  to afford Compound 2; b) reacting Compound 2 in an oxidation reaction to afford Compound 3; c) which is subsequently reacted in a reductive amination  to afford Compound 4; d) Compound 4 is reacted in a protection step using a benzyl protecting agent and base in a solvent at a temperature of about 70° C. to afford Compound 5 of the formula e) which is subsequently reacted in a deprotection step with an acid in a common organic solvent to afford Compounds 6 and 7 of the formula f) and reacting Compounds 6 and 7 with a benzoyl protecting reagent and a base in an organic solvent to afford Compound 8. 2. The process according to claim 1 wherein the protecting group in step a) is benzyl chloride. 3. The process according to claim 1 wherein the oxidation group in step b) is TEMPO. 4. The process according to claim 1 wherein the reducing group in step c) is BnNH 2 . 5. The process according to claim 1 wherein the protecting group in step d) is BnBr. 6. The process according to claim 1 wherein the base in step d) is a Hunig's base. 7. The process according to claim 1 wherein the deprotecting agent in step e) is TsOH. 8. The process according to claim 1 wherein the protecting group in step f) is Bz 2 O. 9. A process for preparing Compound 15 of the formula a) which comprises reacting Compound 8 using Vorbrüggen chemistry to afford Compound 9 b) which is subsequently deprotected to afford Compound 10 of the formula c) which is then subsequently protected to afford Compounds 11 and 12 of the formula d) which are reacted with a benzoyl protecting reagent to afford Compound 13 of the formula e) Compound 13 is then reacted with ammonia to afford Compound 14 of the formula f) which is subsequently hydrogenated to afford intermediate Compound 15 or Compound 15a 10. The process according to claim 9 wherein the Vorbruggen chemistry reagent in step a) is HA BZ . 11. The process according to claim 9 wherein the deprotecting agent in step b) is KOH. 12. The process according to claim 9 wherein the protecting group in step c) is TSCl. 13. The process according to claim 9 wherein the benzyl protecting group in step d) is BzCl. 14. The process according to claim 9 wherein the hydrogenation reagent in step f) is PdCl 2 or Pd/C. 15. A process for preparing Compound 22 of the formula which comprises a) reacting Compound 8 using Vorbrüggen chemistry to afford Compound 16 of the formula b) which is hydrolyzed to afford Compound 17; c) which is subsequently deprotected to afford Compound 18 of the formula d) which is then protected to afford Compound 19 of the formula, e) which is further protected using an isobutyryl containing reagent to afford Compound 20 of the formula, or alternatively, Compound 19 is reacted to afford Compound 23 which is further protected using an isobutyryl containing reagent to afford Compound 20 f) which is deprotected under acidic conditions to afford Compound 21 of the formula g) which is then hydrogenated to afford Compound 22. 16. The process according to claim 15 wherein the Vorbruggen chemistry reagent in step a) is HG CL . 17. The process according to claim 15 wherein the hydrolyzing agent in step b) is TsOH. 18. The process according to claim 15 wherein the deprotecting agent in step c) is KOH. 19. The process according to claim 15 wherein the protecting agent in step d) is TBSCl. 20. The process according to claim 15 wherein the isobutyl protecting group in step e) is iBuCOCl. 21. The process according to claim 15 wherein the deprotecting agent in step f) is TsOH. 22. The process according to claim 15 wherein the hydrogenation reagent in step g) is Pd/C. 23. A compound selected from the following

Assignees

Inventors

Classifications

  • Aminosugars · CPC title

  • C07H1/00Primary

    Processes for the preparation of sugar derivatives · CPC title

  • C07H19/167Primary

    with ribosyl as the saccharide radical · CPC title

  • C07H5/04Primary

    to nitrogen · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US12060384B2 cover?
The invention generally relates to improved processes for the preparation of intermediates of a cyclic dinucleotide which is useful as a STING agonist.
Who is the assignee on this patent?
Bristol Myers Squibb Co
What technology area does this patent fall under?
Primary CPC classification C07H1/00. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Aug 13 2024 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).